Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain

This publication has 29 references indexed in Scilit:

• Augmentation with a 5-HT1A, but not a 5-HT1B receptor antagonist critically depends on the dose of citalopram
  European Journal of Pharmacology, 2000
• Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex
  NeuroReport, 1999
• Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses
  Cephalalgia, 1998
• The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats
  European Journal of Pharmacology, 1998
• Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood–brain barrier
  Brain Research Reviews, 1997
• Rizatriptan has central antinociceptive effects against durally evoked responses
  European Journal of Pharmacology, 1997
• Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine ?
  Pain, 1996
• The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex
  Neuropharmacology, 1994
• Determination of sumatriptan succinate in plasma and urine by high-performance liquid chromatography with electrochemical detection
  Journal of Pharmaceutical Sciences, 1993
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973